Acadia Pharmaceuticals (ACAD.MX) Q4 2023 Earnings

Nov 2Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-7.89
-5.21
-2.52
0.17

Details

Expected EPS
-7.892851500000001
Actual EPS
-7.015868000000001
Surprise EPS
0.88
Surprise Percent
+11.11%

Description

⁨Acadia Pharmaceuticals⁩ (⁦ACAD.MX⁩) has reported earnings of ⁦-7.015868000000001⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts